Profile
Full Name
eFFECTOR Therapeutics, Inc.Ticker Symbol
EFTRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 1, 2021Indexes
Not includedWebsite
http://effector.comEmployees
14Key Details
Price
$0.00(0.00%)
Market cap
$940.88(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$16.37(-18.97% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
eFFECTOR Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 28, 24 HC Wainwright & Co.
BuyFeb 6, 24 HC Wainwright & Co.
BuyNov 14, 23 HC Wainwright & Co.
BuyAug 24, 23 HC Wainwright & Co.
BuyMay 26, 23 Stifel
BuyMay 10, 23 Credit Suisse
OutperformMar 9, 23 Credit Suisse
OutperformJan 9, 23 JMP Securities
Market OutperformJan 6, 23 Credit Suisse
OutperformNov 17, 22 JMP Securities
Market OutperformInstitutional Ownership
- What is the ticker symbol for eFFECTOR Therapeutics?
- Does eFFECTOR Therapeutics pay dividends?
- What sector is eFFECTOR Therapeutics in?
- What industry is eFFECTOR Therapeutics in?
- What country is eFFECTOR Therapeutics based in?
- When did eFFECTOR Therapeutics go public?
- Is eFFECTOR Therapeutics in the S&P 500?
- Is eFFECTOR Therapeutics in the NASDAQ 100?
- Is eFFECTOR Therapeutics in the Dow Jones?
- When was eFFECTOR Therapeutics's last earnings report?
- When does eFFECTOR Therapeutics report earnings?
- Should I buy eFFECTOR Therapeutics stock now?
What is the ticker symbol for eFFECTOR Therapeutics?
The ticker symbol for eFFECTOR Therapeutics is NASDAQ:EFTR
Does eFFECTOR Therapeutics pay dividends?
No, eFFECTOR Therapeutics does not pay dividends
What sector is eFFECTOR Therapeutics in?
eFFECTOR Therapeutics is in the Healthcare sector
What industry is eFFECTOR Therapeutics in?
eFFECTOR Therapeutics is in the Biotechnology industry
What country is eFFECTOR Therapeutics based in?
eFFECTOR Therapeutics is headquartered in United States
When did eFFECTOR Therapeutics go public?
eFFECTOR Therapeutics's initial public offering (IPO) was on March 1, 2021
Is eFFECTOR Therapeutics in the S&P 500?
No, eFFECTOR Therapeutics is not included in the S&P 500 index
Is eFFECTOR Therapeutics in the NASDAQ 100?
No, eFFECTOR Therapeutics is not included in the NASDAQ 100 index
Is eFFECTOR Therapeutics in the Dow Jones?
No, eFFECTOR Therapeutics is not included in the Dow Jones index
When was eFFECTOR Therapeutics's last earnings report?
eFFECTOR Therapeutics's most recent earnings report was on May 9, 2024
When does eFFECTOR Therapeutics report earnings?
The date for eFFECTOR Therapeutics's next earnings report has not been announced yet
Should I buy eFFECTOR Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions